David Moss | Co-Founder and Chief Financial Officer |
RJ Tesi | Chairman and Chief Executive Officer |
CJ Barnum | Head of Neuroscience |
William Wood | B. Riley Securities |
Matthew Cross | Alliance Global Partners |
Sung Hong | BTIG |
Daniel Carlson | TW Research Group |
Greetings, and welcome to the INmune Bio First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call.